These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 9127466)
1. Intraindividual variability in bone markers in the urine. Jensen JE; Kollerup G; Sørensen HA; Sørensen OH Scand J Clin Lab Invest Suppl; 1997; 227():29-34. PubMed ID: 9127466 [TBL] [Abstract][Full Text] [Related]
2. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling]. Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165 [TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of bone turnover markers in healthy premenopausal women. de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821 [TBL] [Abstract][Full Text] [Related]
4. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis. Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083 [TBL] [Abstract][Full Text] [Related]
5. [Usefulness of biochemical markers of bone turnover in diagnosis of osteoporosis]. Pluskiewicz W; Stempniewicz E Przegl Lek; 1994; 51(3):149-51. PubMed ID: 8058983 [TBL] [Abstract][Full Text] [Related]
6. Establishing a reference range for bone turnover markers in young, healthy women. Glover SJ; Garnero P; Naylor K; Rogers A; Eastell R Bone; 2008 Apr; 42(4):623-30. PubMed ID: 18289953 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889 [TBL] [Abstract][Full Text] [Related]
8. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460 [TBL] [Abstract][Full Text] [Related]
9. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. Garnero P; Delmas PD J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078 [TBL] [Abstract][Full Text] [Related]
10. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis]. Garnero P; Delmas PD Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740 [TBL] [Abstract][Full Text] [Related]
11. Determination of NTx in second-morning urine: a proposal for the standardization of morning urine collection. Wendlová J; Mikulecký M Wien Med Wochenschr; 2001; 151(18-20):472-5. PubMed ID: 11817260 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women. Uretmen S; Gol M; Cimrin D; Irmak E Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419 [TBL] [Abstract][Full Text] [Related]
13. The bone marker plot: an innovative method to assess bone turnover in women. Bieglmayer C; Kudlacek S Eur J Clin Invest; 2009 Mar; 39(3):230-8. PubMed ID: 19260953 [TBL] [Abstract][Full Text] [Related]
14. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis. Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575 [TBL] [Abstract][Full Text] [Related]
15. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. Asaba Y; Hiramatsu K; Matsui Y; Harada A; Nimura Y; Katagiri N; Kobayashi T; Takewaka T; Ito M; Niida S; Ikeda K Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925 [TBL] [Abstract][Full Text] [Related]
16. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Shaarawy M; Zaki S; Sheiba M; El-Minawi AM Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333 [TBL] [Abstract][Full Text] [Related]
17. Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis. Nawawi HM; Yazid TN; Ismail NM; Mohamad AR; Nirwana SI; Khalid BA Malays J Pathol; 2001 Dec; 23(2):79-88. PubMed ID: 12166596 [TBL] [Abstract][Full Text] [Related]
18. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis]. Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527 [TBL] [Abstract][Full Text] [Related]
19. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661 [TBL] [Abstract][Full Text] [Related]
20. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis. Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]